Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftin Cream 2% in Pediatric Tinea Corporis
NCT02227290Phase 4Completed
- Sponsor
- Merz
- Start
- Aug 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of naftifine organogel (MediQuest Therapeutics) in tinea corporis, sponsored by Merz. Started Aug 2014; status: completed.
02
Drugs
naftifine organogel (MediQuest Therapeutics)
03
Conditions
tinea corporis
Beyond the preview
Go deeper on NCT02227290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02227290.